among the new cephalosporins , only ceftazidime shows promise in clinical trial , and the results of the fourth european organization for research on treatment of cancer ( eortc ) trial , which includes the combination of amikacin plus ceftazidime , are awaited with interest .
C3536856
cephalosporins
C0007559
ceftazidime